ZEISS Ventures
ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, headquartered in Oberkochen, Germany. It is a strategic deep-tech investor targeting pre-Series A and Series A start-ups in Industrial Tech, MedTech and Life Sciences, writing initial tickets of EUR 0.5-5 million from an evergreen balance-sheet-funded programme. The team focuses on technology-driven ventures combining software and hardware with scalable global B2B business models, primarily across Europe and North America.
Key facts
Recent exits
Coverage notes
1 fund tracked, 16 portfolio companies (13 active · 3 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund ZEISS Ventures has raised, with its portfolio companies. Hand-checked from public filings.
ZEISS Ventures CVCEvergreen2019 · 7yr€140M13 active · 3 realized
Unrealized
13 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| arcoris bio | Biotech | Switzerland | 2025 |
| CREAL | Deep Tech | Switzerland | 2024 |
| Custom Surgical | MedTech | Germany | 2026 |
| Hypervision Surgical | MedTech | United Kingdom | 2023 |
| InSphero | Biotech | Switzerland | 2023 |
| Lidrotec | Deep Tech | Germany | 2025 |
| Maculaser | MedTech | Finland | 2026 |
| Mindpeak | Healthcare | Germany | 2024 |
| Morrow | Consumer | Norway | 2022 |
| Odne | MedTech | Switzerland | 2025 |
| Surgify Medical | MedTech | Finland | 2025 |
| Vibrosonic | MedTech | Germany | 2023 |
| ZOMP | MedTech | United Kingdom | 2023 |
Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Bridger Photonics | Deep Tech | United States | 2018 | 2022 | Trade Sale | – | – |
| Nanoscribe | Deep Tech | Germany | 2008 | 2021 | Trade Sale | – | |
| Scantinel Photonics | Deep Tech | Germany | 2021 | 2025 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.